Published in J Antimicrob Chemother on October 01, 1999
Adaptive resistance to biocides in Salmonella enterica and Escherichia coli O157 and cross-resistance to antimicrobial agents. J Clin Microbiol (2004) 1.27
The Bifidobacterium longum NCIMB 702259T ctr gene codes for a novel cholate transporter. Appl Environ Microbiol (2006) 0.96
Impact of dose de-escalation and escalation on daptomycin's pharmacodynamics against clinical methicillin-resistant Staphylococcus aureus isolates in an in vitro model. Antimicrob Agents Chemother (2011) 0.80
Preventing the risk of emergence of bacterial resistance associated with antibiotic therapy: what role for pharmacokinetic and pharmacodynamic data? J Antimicrob Chemother (2002) 0.75
Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry (1965) 96.68
Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial. Lancet (1999) 4.68
Brucellosis from sniffing bacteriological cultures. Lancet (1997) 1.70
Contagious yawning in gelada baboons as a possible expression of empathy. Proc Natl Acad Sci U S A (2009) 1.61
The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohort. J Acquir Immune Defic Syndr (2001) 1.51
[Prognosis of acute tuberculous respiratory distress syndrome. 4 cases]. Presse Med (1995) 1.39
[Aspergillus fumigatus muscle abscess revealing invasive aspergillosis in a patient with AIDS]. Presse Med (1998) 1.38
Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity. Antimicrob Agents Chemother (1990) 1.35
A large French prospective cohort of HIV-infected patients: the Nadis Cohort. HIV Med (2009) 1.29
Persisting long-term benefit of genotype-guided treatment for HIV-infected patients failing HAART. The Viradapt Study: week 48 follow-up. Antivir Ther (2000) 1.24
Comparison of clinical treatment decisions with US National Institutes of Health consensus indications for lower third molar removal. Br Dent J (1993) 1.22
Risk of invasive cervical cancer among women with, or at risk for, HIV infection. Int J Cancer (1999) 1.20
The spectrum of SLC17A5-gene mutations resulting in free sialic acid-storage diseases indicates some genotype-phenotype correlation. Am J Hum Genet (2000) 1.19
A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne). J Infect Dis (1999) 1.12
In vitro selection of mutants of Streptococcus pneumoniae resistant to macrolides and linezolid: relationship with susceptibility to penicillin G or macrolides. J Antimicrob Chemother (2005) 1.10
[Infarction of the caudate nucleus or anterior striato-capsular infarction?]. Rev Neurol (Paris) (1994) 1.09
Epidemiology of bacterial infection during management of open leg fractures. Eur J Clin Microbiol Infect Dis (1999) 1.08
Antigenic and biochemical analysis of influenza "A" H3N2 viruses isolated from pigs. Arch Virol (1985) 1.07
In the era of highly active antiretroviral therapy, why are HIV-infected patients still admitted to hospital for an inaugural opportunistic infection? HIV Med (2005) 1.07
Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug users. J Epidemiol Community Health (2002) 1.07
Spontaneous middle cerebral artery reperfusion in ischemic stroke. A follow-up study with transcranial Doppler. Stroke (1995) 1.06
A study of nineteen immunocompromised patients with extensive skin lesions caused by Pseudomonas aeruginosa with and without bacteremia. Acta Derm Venereol (1991) 1.06
Effects of subinhibitory concentrations of vancomycin and teicoplanin on adherence of staphylococci to tissue culture plates. Antimicrob Agents Chemother (1993) 1.05
Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trial. HIV Med (2009) 1.05
Overexpression of Fas/CD95 and Fas-induced apoptosis in a patient with idiopathic CD4+ T lymphocytopenia. Clin Infect Dis (1999) 1.04
Cutaneous leishmaniasis due to Leishmania infantum. Case reports and literature review. Arch Dermatol (1998) 1.04
Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus. J Infect Dis (2002) 1.03
Efficacy of subinhibitory concentration of pefloxacin in preventing experimental Staphylococcus aureus foreign body infection in mice. Drugs Exp Clin Res (1992) 1.00
Transcranial Doppler in acute hemispheric brain infarction. Neurology (1991) 0.98
Allopurinol for treatment of visceral leishmaniasis in patients with AIDS. J Infect Dis (1989) 0.98
Pneumococcal resistance patterns in Europe. Eur J Clin Microbiol Infect Dis (1997) 0.98
Evaluating counseling outcome on adherence to prophylaxis and follow-up after sexual HIV-risk exposure: a randomized controlled trial. AIDS Care (2010) 0.97
Antibiotic misuse: a prospective clinical audit in a French university hospital. Eur J Clin Microbiol Infect Dis (2007) 0.97
Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group. Ann Intern Med (1997) 0.96
Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (nice SEROCO cohort). J Med Virol (1994) 0.96
HIV resistance to antiretroviral drugs: mechanisms, genotypic and phenotypic resistance testing in clinical practice. Acta Clin Belg (2002) 0.95
Incidence and risk factors of bacterial pneumonia requiring hospitalization in HIV-infected patients started on a protease inhibitor-containing regimen. HIV Med (2006) 0.94
Identification and characterization of multiple splice forms of the human interleukin-23 receptor alpha chain in mitogen-activated leukocytes. Genes Immun (2008) 0.93
Comparison of haemagglutination-inhibition and single radial haemolysis techniques for detecting antibodies to influenza A and B viruses. J Hyg (Lond) (1983) 0.93
Highly active anti-retroviral therapy (HAART) is associated with a lower level of CD4+ T cell apoptosis in HIV-infected patients. Clin Exp Immunol (1999) 0.93
Application of Bayesian estimation for the prediction of an appropriate dosage regimen of amikacin. J Pharm Sci (1989) 0.92
Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART. The Manif-2000 Study Group. Drug Alcohol Depend (2000) 0.92
Adverse effects of parenteral antimicrobial therapy for chronic bone infections. Eur J Clin Microbiol Infect Dis (2008) 0.91
Changing trends in pregnancy outcome among HIV-infected women between 1985 and 1997 in two southern French university hospitals. Eur J Obstet Gynecol Reprod Biol (2002) 0.91
Iatrogenic Cushing's syndrome in an HIV-infected patient treated with inhaled corticosteroids (fluticasone propionate) and low dose ritonavir enhanced PI containing regimen. J Infect (2002) 0.90
The diffusion of pefloxacin into bone and the treatment of osteomyelitis. J Antimicrob Chemother (1986) 0.90
Differences in HIV testing, knowledge and attitudes in pregnant women who deliver and those who terminate: Prevagest 1992--France. AIDS Care (1995) 0.88
Impact of short-term adherence on virological and immunological success of HAART: a case study among French HIV-infected IDUs. Int J STD AIDS (2001) 0.88
Comparison of the effects of temperature and water activity on growth rate of food spoilage moulds. J Ind Microbiol Biotechnol (2002) 0.88
Diarrhea and Campylobacter infections in patients infected with the human immunodeficiency virus. J Infect Dis (1989) 0.87
Intracellular concentration of protease inhibitors in HIV-1-infected patients: correlation with MDR-1 gene expression and low dose of ritonavir. HIV Clin Trials (2002) 0.87
[Bacterial resistance and antibiotic prescriptions: perceptions, attitudes and knowledge of a sample of French GPs]. Med Mal Infect (2010) 0.87
[Senegal and malaria. True prophylactic failure of mefloquine]. Presse Med (2002) 0.87
[Effects of rifampicin on the pharmacokinetics of doxycycline]. Pathol Biol (Paris) (1987) 0.87
In-vitro development of resistance to beta-lactam antibiotics in Streptococcus pneumoniae. J Antimicrob Chemother (1995) 0.87
[Hospital medical students: a population at risk for accidental exposure to blood]. Presse Med (1998) 0.86
[Discriminant factors of the risk of infection in routine digestive surgery. Trial apropos of 308 cases]. Ann Chir (1982) 0.86
Factors related to the prescription of antibiotics for young children with viral pharyngitis by general practitioners and paediatricians in southeastern France. Eur J Clin Microbiol Infect Dis (1999) 0.86
[Motives for the prescription of antibiotics in the emergency department of the University Hospital Center in Nice. A prospective study]. Presse Med (2002) 0.85
Proposal for using tissue culture for the potency test of smallpox vaccine. J Biol Stand (1976) 0.85
[Adherence properties and production of slime by staphylococci: relation to pathogenicity]. Pathol Biol (Paris) (1990) 0.85
New perspectives offered by a French study of antibiotic resistance in day-care centers. Chemotherapy (1998) 0.85
Mycobacterial cutaneous manifestations: a new sign of immune restoration syndrome in patients with acquired immunodeficiency syndrome. Arch Dermatol (1999) 0.85
Patent foramen ovale and transcranial Doppler. Comparison of different procedures. Stroke (1996) 0.85
Skin manifestations of West Nile virus infection. Dermatology (2005) 0.84
Outbreak of typhoid fever on the French Riviera. Eur J Clin Microbiol Infect Dis (2000) 0.84
Fertility and semen quality of workers exposed to high temperatures in the ceramics industry. Reprod Toxicol (1992) 0.84
[A case of external ophthalmomyiasis by Oestrus ovis, Linné, 1758 caught on the Nice beach (author's transl)]. Acta Trop (1981) 0.84
Six weeks antibiotic therapy for all bone infections: results of a cohort study. Eur J Clin Microbiol Infect Dis (2009) 0.83
High-intensity physical exercise disrupts implicit memory in mice: involvement of the striatal glutathione antioxidant system and intracellular signaling. Neuroscience (2010) 0.83
Efficacy, safety and predictive factors of virological success of a boosted amprenavir-based salvage regimen in heavily antiretroviral-experienced HIV-1-infected patients. HIV Med (2004) 0.83
[Tuberculosis discovered in a patient with Sweet's syndrome]. Presse Med (2001) 0.83
Acute renal failure as initial presentation of visceral leishmaniasis in an HIV-1-infected patient. Scand J Infect Dis (2002) 0.83
[Secondary infection of joint implants: diagnostic criteria, treatment and prevention]. Rev Chir Orthop Reparatrice Appar Mot (2002) 0.83
Atypical leishmaniasis in a patient infected with human immunodeficiency virus. Clin Infect Dis (1995) 0.83
Economic evaluation of drug resistance genotyping for the adaptation of treatment in HIV-infected patients in the VIRADAPT study. J Acquir Immune Defic Syndr (2000) 0.83
Increased time exposure to tenofovir is associated with a greater decrease in estimated glomerular filtration rate in HIV patients with kidney function of less than 60 ml/min/1.73 m2. Nephron Clin Pract (2012) 0.82
Role of ageing, chronic renal failure and dialysis in the calcification of mitral annulus. Nephrol Dial Transplant (1993) 0.82
Botulism and hot-smoked whitefish: a family cluster of type E botulism in France, September 2009. Euro Surveill (2009) 0.82
Unusual cutaneous manifestations of miliary tuberculosis. Clin Infect Dis (2000) 0.82